Back to search
FDAFDA · Food and drugs·Recall number Z-0127-2015

Dimension Vista® HbA1c

Published November 5, 2014 · Recall initiated: August 14, 2014

Summary

FDA records medical device Class II recall Z-0127-2015, published November 5, 2014 and initiated August 14, 2014. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Terminated; Reported quantity: 20043; Lot: catalog #K3105A, material #10470481, All in-date lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

In March, Siemens Healthcare Diagnostics issued an Urgent Medical Device Correction for decreased recovery of patient samples with the Dimension Vista® CSA & CSAE Flex® reagent cartridges when whole blood samples are run from Small Sample Containers (SSC). Siemens has confirmed that when whole blood samples are run from SSC, HbA1c values may exhibit a percent bias ranging from - 8.2% t

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Healthcare Diagnostics, Inc.
Distributor
Worldwide Distribution: US (nationwide) and country of: Canada.
Lot
catalog #K3105A, material #10470481, All in-date lots
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Dimension Vista® HbA1c recalled?

Yes. FDA published recall Z-0127-2015 on November 5, 2014. Reported hazard: In March, Siemens Healthcare Diagnostics issued an Urgent Medical Device Correction for decreased recovery of patient samples with the Dimension Vista® CSA & CSAE Flex® reagent cartridges when whole blood samples are run from Small Sample Containers (SSC). Siemens has confirmed that when whole blood samples are run from SSC, HbA1c values may exhibit a percent bias ranging from - 8.2% t

What should I do if I have this product?

Voluntary: Firm initiated · Letter